MEDICINOVA, INC.: 10-Q filed 2018-04-25

Name: MEDICINOVA, INC.: 10-Q filed 2018-04-25
Creator: MEDICINOVA, INC.

What MEDICINOVA, INC. reported in its quarterly report filed 2018-04-25 (fiscal Q1 2018): 26 published measures, 52 facts as tagged in accession 0001564590-18-009050.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-04-25
Fiscal period: fiscal Q1 2018
Accession: 0001564590-18-009050 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-03-31	78,664,744	USD
At 2017-12-31	43,419,064	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-03-31	3,094,937	USD
At 2017-12-31	4,776,924	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-03-31	75,569,807	USD
At 2017-12-31	38,642,140	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-03-31	62,939,203	USD
At 2017-12-31	27,991,743	USD
At 2017-03-31	21,637,156	USD
At 2016-12-31	24,118,037	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-4,543,051	USD	90
2017-01-01 to 2017-03-31	-3,016,524	USD	90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	8,584	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-03-31	-345,999,251	USD
At 2017-12-31	-341,456,200	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	4,060	USD	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-03-31	65,011	USD
At 2017-12-31	62,886	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	2,530,425	USD	90
2017-01-01 to 2017-03-31	1,168,155	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-4,666,581	USD	90
2017-01-01 to 2017-03-31	-3,023,522	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-03-31	63,571,877	USD
At 2017-12-31	28,328,323	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-03-31	1,198,982	USD
At 2017-12-31	2,880,969	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-03-31	361,411	USD
At 2017-12-31	1,520,225	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-03-31	9,600,240	USD
At 2017-12-31	9,600,240	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	4,666,581	USD	90
2017-01-01 to 2017-03-31	3,023,522	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	1,600,000	USD	90
2017-01-01 to 2017-03-31	800,000	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-03-31	41,129,073	shares
At 2017-12-31	36,452,893	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2018-03-31	-88,791	USD
At 2017-12-31	-94,623	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-03-31	10,959	USD
At 2017-12-31	10,958	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-03-31	837,571	USD
At 2017-12-31	1,360,744	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-03-31	632,674	USD
At 2017-12-31	336,580	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-4,543,051	USD	90
2017-01-01 to 2017-03-31	-3,012,464	USD	90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-4,537,221	USD	90
2017-01-01 to 2017-03-31	-3,014,808	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	3,004,735	USD	90
2017-01-01 to 2017-03-31	2,122,861	USD	90

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	6,689	USD	90
2017-01-01 to 2017-03-31	7,217	USD	90

Inspect the source

Entity: MEDICINOVA, INC. / CIK 0001226616
Captured: 2026-09-20T07:46:14.294Z
SEC response SHA-256: 2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))